Data / Research funding / California / Glyphic Biotechnologies, Inc.
Glyphic Biotechnologies, Inc.: 4 NIH awards ($1.6M), fiscal years 2021 to 2026
Glyphic Biotechnologies, Inc. in Menlo Park, CA is funded under 4 NIH awards ($1.6M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- NIH institution profile
- 10066570
- State
- California
- Note
- NIH gives no UEI for this institution, so NSF awards are not matched.
Awards
4 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|
| Single-molecule protein sequencing by iterative isolation and identification of N-terminal amino acids | NIH | National Human Genome Research Institute | 2022 | $409,295 | September 2, 2022 | August 31, 2023 | ESTANDIAN, DANIEL MASAO | reporter.nih.gov |
| Single-molecule sequencing of post-translational protein modifications | NIH | National Institute of General Medical Sciences | 2023 | $408,939 | September 15, 2023 | September 14, 2024 | ESTANDIAN, DANIEL MASAO | reporter.nih.gov |
| Single-molecule protein sequencing by detection and identification of N-terminal amino acids | NIH | National Human Genome Research Institute | 2023 | $390,584 | August 15, 2023 | July 31, 2024 | ESTANDIAN, DANIEL MASAO | reporter.nih.gov |
| Single-molecule protein sequencing by barcoding of N-terminal amino acids | NIH | National Institute of General Medical Sciences | 2023 | $358,981 | September 15, 2023 | September 14, 2024 | ESTANDIAN, DANIEL MASAO | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|
| 2023 | 3 | $1,158,504 | 0 | $0 |
| 2022 | 1 | $409,295 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|
| Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed) | PAR-25-255 | NIH | 93.172 | November 5, 2026 | Not listed | Same assistance listing 93.172 as 2 awards here |
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) | PAR-25-095 | NIH | 93.172 | November 6, 2026 | $350,000 | Same assistance listing 93.172 as 2 awards here |
| Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional) | RFA-OD-27-009 | NIH | 93.859 | November 10, 2026 | Not listed | Same assistance listing 93.859 as 2 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.172 | November 16, 2026 | $50,000 | Same assistance listing 93.172 as 2 awards here |
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) | PAR-25-096 | NIH | 93.172 | November 17, 2026 | $200,000 | Same assistance listing 93.172 as 2 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.172 | November 18, 2026 | Not listed | Same assistance listing 93.172 as 2 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.172 | November 18, 2026 | Not listed | Same assistance listing 93.172 as 2 awards here |
| Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional) | PA-23-317 | NIH | 93.172 | November 24, 2026 | Not listed | Same assistance listing 93.172 as 2 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) | PAR-24-295 | NIH | 93.172 | December 3, 2026 | Not listed | Same assistance listing 93.172 as 2 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) | PAR-24-296 | NIH | 93.172 | December 3, 2026 | Not listed | Same assistance listing 93.172 as 2 awards here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.172 | December 4, 2026 | Not listed | Same assistance listing 93.172 as 2 awards here |
| Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed) | RFA-HG-27-007 | NIH | 93.172 | December 14, 2026 | $2 million | Same assistance listing 93.172 as 2 awards here |
| IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed) | RFA-HG-27-008 | NIH | 93.172 | December 14, 2026 | $4 million | Same assistance listing 93.172 as 2 awards here |
| Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed) | RFA-HG-27-009 | NIH | 93.172 | December 14, 2026 | $1.5 million | Same assistance listing 93.172 as 2 awards here |
| Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed) | RFA-HG-27-010 | NIH | 93.172 | December 14, 2026 | $800,000 | Same assistance listing 93.172 as 2 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) | PAR-27-039 | NIH | 93.172 | January 5, 2027 | Not listed | Same assistance listing 93.172 as 2 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) | PAR-27-040 | NIH | 93.172 | January 5, 2027 | Not listed | Same assistance listing 93.172 as 2 awards here |
| Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed) | PAR-25-256 | NIH | 93.172 | January 7, 2027 | Not listed | Same assistance listing 93.172 as 2 awards here |
| Medical Scientist Training Program (MSTP) (T32) | PAR-24-128 | NIH | 93.859 | January 25, 2027 | Not listed | Same assistance listing 93.859 as 2 awards here |
| Tribal Undergraduate to Graduate Research Training and Leadership Experiences (TURTLE) Program (UE5/T32) | PAR-24-235 | NIH | 93.859 | January 25, 2027 | Not listed | Same assistance listing 93.859 as 2 awards here |
Topics of its NIH awards
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.